Safflower Oil

CHEMBL1201660 Phase 4 Aprovado Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Safflower oil is a polyunsaturated fatty acid-rich vegetable oil derived from Carthamus tinctorius seeds, used as a dietary supplement and investigated in conditions including asthma and bipolar disorder. Its high linoleic acid content is thought to modulate eicosanoid production and membrane lipid composition, with potential anti-inflammatory and mood-stabilizing effects. It is also used as a vehicle for parenteral nutrition lipid emulsions.

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Safflower oil is a polyunsaturated fatty acid-rich vegetable oil derived from Carthamus tinctorius seeds, used as a dietary supplement and investigated in conditions including asthma and bipolar disorder. Its high linoleic acid content is thought to modulate eicosanoid production and membrane lipid composition, with potential anti-inflammatory and mood-stabilizing effects. It is also used as a vehicle for parenteral nutrition lipid emulsions.

Yes, Safflower Oil is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201660. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.